LCM
AMLX icon

Landscape Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Landscape Capital Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,226
Closed -$170K – 646
2026
Q1 		$170K Hold
12,226
– – 0.01% 647
2025
Q4 		$148K Buy
12,226
+1,825
+18% +$24.8K 0.01% 639
2025
Q3 		$141K Buy
+10,401
New +$97.9K 0.01% 570
2025
Q1 		– Sell
-49,661
Closed -$188K – 628
2024
Q4 		$188K Buy
+49,661
New +$234K 0.02% 599
2024
Q1 		– Sell
-33,689
Closed -$496K – 734
2023
Q4 		$496K Buy
+33,689
New +$516K 0.04% 409

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Landscape Capital Management's AMLX Position: Q2 2026 in Review

Landscape Capital Management sold out of Amylyx Pharmaceuticals (AMLX) in Q2 2026, closing a stake of 12,226 shares — an estimated $170K sold.

Landscape Capital Management first reported a position in AMLX in Q4 2023 and held it in 5 quarters. The position peaked at $496K in Q4 2023. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Landscape Capital Management reported no remaining Amylyx Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 12,226 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $170K.
  • Landscape Capital Management first reported a position in Amylyx Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Landscape Capital Management's Amylyx Pharmaceuticals position peaked at $496K in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.